Editas Medicine, Inc. operates as a clinical stage genome editing company. The company focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary genome editing platform based on CRISPR technology to target genetically addressable diseases and therapeutic areas. EDIT | Editas Medicine Inc. Stock Price & News - WSJ Editas Medicine Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time EDIT stock price. Dow Jones, a News Corp company.

Editas Medicine, Inc. Common Stock (EDIT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Real-time trade and investing ideas on Editas Medicine Inc. EDIT from the largest community of traders and investors. Investing ideas, stock information, fundamental analysis, technical analysis on EDITAS MEDICINE INC ($EDIT) from Singapore's largest stock investing community. Previous Close 19.980. Buy Price 19.020. Buy Volume 12. Sell Price 19.570. EDITAS MEDICINE share price (0IFK), chart, recent trades, company information, trading information, company news, fundamentals. Stockopedia rates Editas Medicine Inc as a Adventurous Momentum Trap . 5 brokers rate it as a 'Buy'. Click to view NSQ:EDIT's StockReport.

Editas Medicine, Inc. (EDIT) Stock Analysis & News ...

23 Feb 2020 The stock touched a low price of $24.65. Editas Medicine, Inc. had a pretty favorable run when it comes to the market performance. The 1-year  10 Jan 2020 The stock option provides for the purchase of up to 120,000 shares of Editas Medicine common stock at a price of $30.65 per share, the closing  10 Jan 2020 10, 2020 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), of Editas Medicine common stock at a price of $30.65 per share, the  Editas Medicine, Inc Stock Chart and Share Price Forecast, Short-Term "EDIT" Stock Prediction 

EDIT | Editas Medicine Inc. Stock Price & News - WSJ

Stock analysis for Editas Medicine Inc (EDIT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced  View today's stock price, news and analysis for Editas Medicine Inc. (EDIT). Barron's also provides information on historical stock ratings, target prices, company 

Editas Medicine Inc., EDIT Options Chain - (NAS) EDIT ...

Mar 26, 2020 · Editas Medicine, Inc. (EDIT) Company Press Releases – Get the latest press release for Editas Medicine, Inc. and all the companies you research at NASDAQ.com Editas Medicine Or Crocs, Inc.: We See Crocs As The Better ...

Historical index on US Stock Market : B+ "Should I invest in Editas Medicine stock?" "Should I trade "EDIT" stock today?" According to our live Forecast System, Editas Medicine, Inc stock is a very good long-term (1-year) investment*. "EDIT" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis.

Editas Medicine Inc (EDIT) Quote | Morningstar Editas Medicine Inc. EDIT Morningstar Rating Rating as of Apr 3, 2020. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance

View detailed financial information, real-time news, videos, quotes and analysis on Editas Medicine Inc. (NASDAQ:EDIT). Explore commentary on Editas Medicine Inc. and hear what the experts at Editas Medicine Inc Stock Quote: EDIT Stock News, Quotes ...